全球放射性皮膚炎市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

全球放射性皮膚炎市場需求預計將從 2023 年的 5.0241 億美元達到 2032 年的近 8.1693 億美元，2024-2032 年研究期間複合年成長率為 5.55%。

放射性皮膚炎、放射性皮膚炎或X光皮膚炎是癌症腫瘤放射治療的外束電離輻射引起的皮膚損傷或放射性燒傷。它也可能很少由介入手術（例如栓塞手術、冠狀動脈造影和留置導管置入）期間暴露於輻射引起。放射性皮膚炎主要採用外用藥物治療，如皮質類固醇、外用抗生素、親水性乳膏、口服藥物如口服皮質類固醇、口服止痛藥、抗發炎藥、抗生素和敷料。

市場動態

越來越多的手術，包括放射治療、栓塞手術、冠狀動脈造影和留置導管放置，導致放射性皮膚炎盛行率增加。癌症負擔的不斷增加以及調強放射治療等放射治療技術的進步正在推動全球放射性皮膚炎市場的發展。放射治療是放射性皮膚炎發生率上升的主要原因。放射治療仍然是癌症治療的重要組成部分，近 50% 的癌症患者在治療期間的某個時刻接受放射治療。減少放射治療相關副作用的努力預計將為預測時間內的市場擴張提供利潤豐厚的機會。然而，缺乏認知以及與放射性皮膚炎治療相關的高成本預計將限制市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球放射性皮膚炎市場的每個細分市場進行了包容性評估。放射性皮膚炎產業的成長和趨勢為本研究提供了整體方法。

市場區隔

放射性皮膚炎市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

• 口服藥物（皮質類固醇、口服止痛藥和抗生素）
• 外用（皮質類固醇、親水性乳膏、外用抗生素）
• 敷料（水凝膠、水膠體、無刺隔離膜、蜂蜜紗布、矽酮塗層敷料等）

按配銷通路

• 醫院藥房
• 零售藥局
• 網路藥局
• 零售藥局

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲放射性皮膚炎市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。放射性皮膚炎市場的主要參與者包括 3M 公司、MeInlycke Health Care AB、Smith & Nephew Plc、Integra Lifesciences Holdings Corporation、Intermed SA、ConvaTec Group Plc、BMG Pharma SPA 本節包括競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：放射性皮膚炎 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按產品分類的市場吸引力分析
  • 按配銷通路分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球輻射皮膚炎市場分析：按產品

• 概述（按產品）
• 按產品分類的歷史和預測資料分析
• 口服藥物（皮質類固醇、口服止痛藥和抗生素）
• 外用（皮質類固醇、親水性乳膏、外用抗生素）
• 敷料（水凝膠、水膠體、無刺隔離膜、蜂蜜紗布、矽酮塗層敷料等）

第 6 章：全球放射性皮膚炎市場分析：按分銷管道

• 配銷通路概述
• 按配銷通路進行歷史和預測資料分析
• 醫院藥房
• 零售藥局
• 網路藥局
• 零售藥局

第 7 章：全球放射性皮膚炎市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區按國家銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲按國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 8 章：放射性皮膚炎公司的競爭格局

• 放射性皮膚炎市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 9 章：公司簡介

• 頂級公司市佔率分析
• 市場集中度
• 3M Company
• 公司概況
• 公司收入
• 產品
• 最新動態
• MeInlycke Health Care AB
• 公司概況
• 公司收入
• 產品
• 最新動態
• Smith & Nephew Plc
• 公司概況
• 公司收入
• 產品
• 最新動態
• Integra Lifesciences Holdings Corporation
• 公司概況
• 公司收入
• 產品
• 最新動態
• Intermed SA
• 公司概況
• 公司收入
• 產品
• 最新動態
• ConvaTec Group Plc
• 公司概況
• 公司收入
• 產品
• 最新動態
• BMG Pharma SPA
• 公司概況
• 公司收入
• 產品
• 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

The global demand for Radiation Dermatitis Market is presumed to reach the market size of nearly USD 816.93 Million by 2032 from USD 502.41 Million in 2023 with a CAGR of 5.55% under the study period 2024-2032.

Radiation dermatitis, radiodermatitis, or x-ray dermatitis is skin damage or a radiation burn caused by external beam ionizing radiation of radiotherapy for cancer tumors. It may also rarely result from exposure to radiation during interventional procedures such as embolization procedures, coronary angiography, and indwelling catheter placements. Radiation dermatitis is primarily treated with topical agents such as corticosteroids, topical antibiotics, hydrophilic creams, oral medications like oral corticosteroids, oral analgesics, anti-inflammatory agents, antibiotics, and dressings.

MARKET DYNAMICS

A rising number of procedures, including radiotherapy, embolization procedures, coronary angiography, and indwelling catheter placements, are responsible for increasing radiation dermatitis prevalence. The escalating burden of cancer and advances in radiation delivery technology, such as intensity-modulated radiation therapy, is driving the global radiation dermatitis market. Radiotherapy is majorly contributing to the rising radiation dermatitis incidences. Radiation therapy remains an essential component of cancer treatment, with nearly 50% of cancer patients receiving radiation therapy at some point during their treatment. Rising effort towards reducing side effects associated with radiation therapy is expected to offer lucrative opportunities for the market expansion during the forecast timeframe. However, lack of awareness and the high cost associated with radio dermatitis treatment is anticipated to restrict the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Radiation Dermatitis. The growth and trends of Radiation Dermatitis industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Radiation Dermatitis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Oral Medication (Corticosteroids, Oral analgesics & Antibiotics)
• Topical (Corticosteroids, Hydrophilic Creams, Topical Antibiotics)
• Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressing, Others)

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Retail Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Radiation Dermatitis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Radiation Dermatitis market include 3M Company, MeInlycke Health Care AB, Smith & Nephew Plc, Integra Lifesciences Holdings Corporation, Intermed S.A, ConvaTec Group Plc, BMG Pharma S.P.A. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. RADIATION DERMATITIS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Distribution Channel
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL RADIATION DERMATITIS MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Oral Medication (Corticosteroids, Oral analgesics & Antibiotics) Historic and Forecast Sales By Regions
• 5.4. Topical (Corticosteroids, Hydrophilic Creams, Topical Antibiotics) Historic and Forecast Sales By Regions
• 5.5. Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressing, Others) Historic and Forecast Sales By Regions

6. GLOBAL RADIATION DERMATITIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 6.1. Overview By Distribution Channel
• 6.2. Historical and Forecast Data Analysis By Distribution Channel
• 6.3. Hospital Pharmacies Historic and Forecast Sales By Regions
• 6.4. Retail Pharmacies Historic and Forecast Sales By Regions
• 6.5. Online Pharmacies Historic and Forecast Sales By Regions
• 6.6. Retail Pharmacies Historic and Forecast Sales By Regions

7. GLOBAL RADIATION DERMATITIS MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE RADIATION DERMATITIS COMPANIES

• 8.1. Radiation Dermatitis Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF RADIATION DERMATITIS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. 3M Company
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. MeInlycke Health Care AB
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. Smith & Nephew Plc
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. Integra Lifesciences Holdings Corporation
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. Intermed S.A
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. ConvaTec Group Plc
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. BMG Pharma S.P.A
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product (USD MN)
• Oral Medication (Corticosteroids, Oral analgesics & Antibiotics) Market Sales By Geography (USD MN)
• Topical (Corticosteroids, Hydrophilic Creams, Topical Antibiotics) Market Sales By Geography (USD MN)
• Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressing, Others) Market Sales By Geography (USD MN)
• Analysis By Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales By Geography (USD MN)
• Retail Pharmacies Market Sales By Geography (USD MN)
• Online Pharmacies Market Sales By Geography (USD MN)
• Retail Pharmacies Market Sales By Geography (USD MN)
• Global Radiation Dermatitis Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Radiation Dermatitis Report
• Market Research Process
• Market Research Methodology
• Global Radiation Dermatitis Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product
• Market Attractiveness Analysis By Distribution Channel
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Product (USD MN)
• Oral Medication (Corticosteroids, Oral analgesics & Antibiotics) Market Sales By Geography (USD MN)
• Topical (Corticosteroids, Hydrophilic Creams, Topical Antibiotics) Market Sales By Geography (USD MN)
• Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressing, Others) Market Sales By Geography (USD MN)
• Global Market Analysis By Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales By Geography (USD MN)
• Retail Pharmacies Market Sales By Geography (USD MN)
• Online Pharmacies Market Sales By Geography (USD MN)
• Retail Pharmacies Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.